Effects of dapagliflozin on cardiovascular and kidney events by baseline eGFR and UACR in patients with type 2 diabetes mellitus: a patient-level pooled analysis of DECLARE-TIMI 58 and DAPA-CKD trials

被引：0
|
作者：
Moura, F. [1 ]
Wiviott, S. [1 ]
Chertow, G. [2 ,3 ]
Dwyer, J. [4 ]
Gause-Nilsson, I [5 ]
Johansson, P. [5 ]
Langkilde, A. [5 ]
McMurray, J. [6 ]
Mosenzon, O. [6 ]
Raz, I [7 ]
Rossing, P. [8 ]
Wheeler, D. [9 ]
Sabatine, M. [1 ]
Heerspink, H. [10 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc Med, TIMI Study Grp, Boston, MA USA
[2] Dept Epidemiol & Populat Hlth, Sch Med, Stanford, CA USA
[3] Dept Med, Stanford, CA USA
[4] Univ Utah Hlth Care, Salt Lake City, UT USA
[5] AstraZeneca, Cambridge, England
[6] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
[7] Hebrew Univ Jerusalem, Hadassah Med Ctr, Diabet Unit, Jerusalem, Israel
[8] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[9] UCL, Dept Renal Med, London, England
[10] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands
来源：
EUROPEAN HEART JOURNAL | 2022年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2407 / 2407
页数：1
相关论文
共 43 条
  • [41] Effects of intensive glucose lowering in treatment of type 2 diabetes mellitus on cardiovascular outcomes: A meta-analysis of data from 58,160 patients in 13 randomized controlled trials
    Fang, Hong-Juan
    Zhou, Yu-Hao
    Tian, Yong-Ji
    Du, Han-Yang
    Sun, Yan-Xia
    Zhong, Li-Yong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 218 : 50 - 58
  • [42] Effects of glucagon-tike peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials
    Marsico, Fabio
    Paolillo, Stefania
    Gargiulo, Paola
    Bruzzese, Dario
    Dell'Aversana, Simona
    Esposito, Immacolata
    Renga, Francesco
    Esposito, Luca
    Marciano, Caterina
    Dellegrottaglie, Santo
    Iesu, Ivana
    Filardi, Pasquale Perrone
    EUROPEAN HEART JOURNAL, 2020, 41 (35) : 3346 - +
  • [43] Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7% Results From the CREDENCE Trial
    Cannon, Christopher P.
    Perkovic, Vlado
    Agarwal, Rajiv
    Baldassarre, James
    Bakris, George
    Charytan, David M.
    de Zeeuw, Dick
    Edwards, Robert
    Greene, Tom
    Heerspink, Hiddo J. L.
    Jardine, Meg J.
    Levin, Adeera
    Li, Jing-Wei
    Neal, Bruce
    Pollock, Carol
    Wheeler, David C.
    Zhang, Hong
    Zinman, Bernard
    Mahaffey, Kenneth W.
    CIRCULATION, 2020, 141 (05) : 407 - 410
12345